Lactin-V significantly reduces recurrence of bacterial vaginosis

Women between the ages of 18 and 45 years received vaginally administered Lactobacillus crispatus CTV-05 or placebo.
Women between the ages of 18 and 45 years received vaginally administered Lactobacillus crispatus CTV-05 or placebo.